Diaxonhit Agrees to Commercialize in Europe the XDx AlloMap[R] Heart Transplant Test Following the Completion of Exclusive License Agreement.
In: Business Wire, 2013-06-27
Zeitungsartikel
Zugriff:
Titel: |
Diaxonhit Agrees to Commercialize in Europe the XDx AlloMap[R] Heart Transplant Test Following the Completion of Exclusive License Agreement.
|
---|---|
Zeitschrift: | Business Wire, 2013-06-27 |
Veröffentlichung: | 2013 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|